Notably, given the potential utility of BET domain inhibitors for the treatment of various cancers [23, 28-30, 32, 33], these findings provide additional insight into the molecular mechanisms by which BRD4 functions in ERα-regulated gene transcription. The gene discussed is DNER; the disease is cancer.